Grant: Engage Grants Program
University of Western Ontario
$25,000.00
Development of a wireless hardware interface for electromyography signals
FY 2014-15
Summary
Intronix Technologies Corporation designs and produces progressive portable medical devices for neuromuscular diagnostics and treatment delivery. Its innovations in injection guidance provide technology that drives clinical solutions todeliver confidence, improve workflow efficiency, and provide a better patient experience. Intronix has extensive experience within the neuromuscular diagnostic and treatment delivery market. Intronix quality system is registered to both ISO 9001:2008 and ISO 13485:2003 (CMDCAS), and is fully USFDA compliant. Intronix lead product, Myoguide Injection Guidance Device, is a revenue-generating product sold and distributed in international markets by our growing distribution network. Myoguide has a Canadian Medical device license, a TüV certificate, and has received a CE Mark and FDA 510(k). Intronix is ready and has been working on developing a new product that will continue to serve our existing target market within the neuromuscular diagnostics and treatment delivery sector. This project will provide the technical expertise and support needed to complete, and shorten the time to market, of our new product. This new product will help generate significant new revenues and add 2-3 Ontario jobs at Intronix within 2-3 years following the completion of this project (up to 5 full-time employees + management + outside contractors). This product will access a $1.5 billion market, served by over 500,000 clinicians, delivering treatment to over 80 million patients, who will benefit from neuromuscular diagnostics and treatment delivery. Our 5-year revenue projections will grow the company from under $1M to approach $12M in sales.The proposed new product presents a low cost approach to the EMG/EEG market. The goal is to produce a multi-functionhandheld device that can be used for routine electromyography (EMG), nerve conduction studies (NCS), neuromuscularstimulation, routine electroencephalography (EEG), sleep studies, and our Myoguide injection guidance for therapeuticBotulinum Toxin injections. While there will be several standalone functions, wireless communication will engage outboardcomputing devices such as a tablet or laptop to add processing power for several complex operations, documentation andelectronic medical records. We will continue to develop our existing software platform to accommodate the technologydeveloped by this project.This new portable device will replace the existing cart based system, provide needed portability, and create an opportunityfor neuromuscular diagnostics and treatment delivery outside of typical clinical and hospital based locations. Disruptivepricing will contribute to lower costs for new equipment; portability will improve availability of diagnostic and treatmentdelivery; and battery operation will create possibilities outside of the power grid.This proposal is focused on development of technical innovations that will arise out of collaboration between the Canadianmedical device manufacturer, Intronix Technologies Corporation, and Dr. Ana Luisa Trejos research team at the Universityof Western Ontario. This partnership will develop input specifications and ultimately create a wireless, battery operated device capable of serving as a biofeedback controller for a rehabilitation device under development within Dr. Trejoslaboratory, as well as serving as a hardware platform for a multifunctional neuromuscular diagnostic and treatment deliverydevice being developed at Intronix.The aim of this work is to complete the first steps towards the development of a wireless device able to transmit muscleactivity signals to an outboard computer for processing. The research will include development of subject techniques neededto acquire biometric data from healthy subjects. The goal is to eventually apply this technology to patients undergoingrehabilitation.
Program
Engage Grants Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
474678-2014
Name nom
Trejos, AnaLuisa
Department département
Electrical and Computer Engineering
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
2514
Research subject group en
Electrical and electronic engineering
Research subject group fr
Génie électrique et électronique
Research subject en
Digital signal processing
Research subject fr
Traitement des signaux numériques
Partie
1
Nb partie
1
Application title
Development of a wireless hardware interface for electromyography signals
Keyword
NSERC
Application summary
Intronix Technologies Corporation designs and produces progressive portable medical devices for neuromuscular diagnostics and treatment delivery. Its innovations in injection guidance provide technology that drives clinical solutions todeliver confidence, improve workflow efficiency, and provide a better patient experience. Intronix has extensive experience within the neuromuscular diagnostic and treatment delivery market. Intronix quality system is registered to both ISO 9001:2008 and ISO 13485:2003 (CMDCAS), and is fully USFDA compliant. Intronix lead product, Myoguide Injection Guidance Device, is a revenue-generating product sold and distributed in international markets by our growing distribution network. Myoguide has a Canadian Medical device license, a TüV certificate, and has received a CE Mark and FDA 510(k). Intronix is ready and has been working on developing a new product that will continue to serve our existing target market within the neuromuscular diagnostics and treatment delivery sector. This project will provide the technical expertise and support needed to complete, and shorten the time to market, of our new product. This new product will help generate significant new revenues and add 2-3 Ontario jobs at Intronix within 2-3 years following the completion of this project (up to 5 full-time employees + management + outside contractors). This product will access a $1.5 billion market, served by over 500,000 clinicians, delivering treatment to over 80 million patients, who will benefit from neuromuscular diagnostics and treatment delivery. Our 5-year revenue projections will grow the company from under $1M to approach $12M in sales.The proposed new product presents a low cost approach to the EMG/EEG market. The goal is to produce a multi-functionhandheld device that can be used for routine electromyography (EMG), nerve conduction studies (NCS), neuromuscularstimulation, routine electroencephalography (EEG), sleep studies, and our Myoguide injection guidance for therapeuticBotulinum Toxin injections. While there will be several standalone functions, wireless communication will engage outboardcomputing devices such as a tablet or laptop to add processing power for several complex operations, documentation andelectronic medical records. We will continue to develop our existing software platform to accommodate the technologydeveloped by this project.This new portable device will replace the existing cart based system, provide needed portability, and create an opportunityfor neuromuscular diagnostics and treatment delivery outside of typical clinical and hospital based locations. Disruptivepricing will contribute to lower costs for new equipment; portability will improve availability of diagnostic and treatmentdelivery; and battery operation will create possibilities outside of the power grid.This proposal is focused on development of technical innovations that will arise out of collaboration between the Canadianmedical device manufacturer, Intronix Technologies Corporation, and Dr. Ana Luisa Trejos research team at the Universityof Western Ontario. This partnership will develop input specifications and ultimately create a wireless, battery operated device capable of serving as a biofeedback controller for a rehabilitation device under development within Dr. Trejoslaboratory, as well as serving as a hardware platform for a multifunctional neuromuscular diagnostic and treatment deliverydevice being developed at Intronix.The aim of this work is to complete the first steps towards the development of a wireless device able to transmit muscleactivity signals to an outboard computer for processing. The research will include development of subject techniques neededto acquire biometric data from healthy subjects. The goal is to eventually apply this technology to patients undergoingrehabilitation.